Screening for Colorectal Cancer

  • John H. Scholefield
  • Susan J. Ritchie

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eurocare 2. IARC Scientific Publications. 1999;51:1–572.Google Scholar
  2. 2.
    Ransahoff D. Screening for colorectal cancer. N Engl J Med. 2002;346:40–44.Google Scholar
  3. 3.
    Atkin W. Screening for colorectal cancer: the heart of the matter. Gut 1999;45:480–481.PubMedCrossRefGoogle Scholar
  4. 4.
    Mandel JS, Bond JH, Church TR. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–1371.CrossRefPubMedGoogle Scholar
  5. 5.
    Hardcastle JD, Chamberlain JO, Robinson MHE. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348:1472–1477.CrossRefPubMedGoogle Scholar
  6. 6.
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–1471.CrossRefPubMedGoogle Scholar
  7. 7.
    Towler B, Irwig L, Glasziou P. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, haemoccult. BMJ. 1998;317:559–565.PubMedGoogle Scholar
  8. 8.
    Robinson M, Hardcastle J, Moss S, et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999;45:588–592.PubMedCrossRefGoogle Scholar
  9. 9.
    Vasen HFA. High incidence of interval cancers in HNPCC. An update of the Dutch HNPCC registry. Paper presented at: 10th Annual ICG-HNPCC Meeting; June 1998; Portugal.Google Scholar
  10. 10.
    Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405–1411.CrossRefPubMedGoogle Scholar
  11. 11.
    Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal occult blood screening in colorectal cancer. Lancet 1996;348:1472–1477.CrossRefPubMedGoogle Scholar
  12. 12.
    Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med. 1993;328:1365–1371.CrossRefPubMedGoogle Scholar
  13. 13.
    Winawer SJ, Schottenfield D, Felhinger BJ. Colorectal cancer screening. J Natl Cancer Inst. 1991; 83:243–253.PubMedGoogle Scholar
  14. 14.
    Atkin WS, Hart A, Edwards R. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998;42:560–565.PubMedCrossRefGoogle Scholar
  15. 15.
    Cannon-Albright LA, Thomas TC, Bishop DT, Skolnick MH, Burt RW. Characteristics of familial colon cancer in a large population database. Cancer 1989;64:1971–1975.PubMedGoogle Scholar
  16. 16.
    Dunlop MG, Farrington SM, Carothers D, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105–110.CrossRefPubMedGoogle Scholar
  17. 17.
    Friedl W, Meuschel S, Caspari, et al. Attenuated familial adenomatous polyposis due to a mutation in the 3″ part of the APC gene. Hum Genet. 1996;97:579–584.CrossRefPubMedGoogle Scholar
  18. 18.
    UK Flexible Sigmoidoscopy Screening Trial Investigation. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline finding of a UK multicentre randomised trial. Lancet 2002;359: 1291–1300.Google Scholar

Copyright information

© Springer-Verlag London Limited 2005

Authors and Affiliations

  • John H. Scholefield
    • 1
  • Susan J. Ritchie
    • 2
  1. 1.Division of Gastrointestinal SurgeryNottingham City HospitalNottinghamUK
  2. 2.Department of Clinical GeneticsNottingham City HospitalNottinghamUK

Personalised recommendations